Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
Abstract Background Interferons (IFN) are implicated in the pathogenesis of anti-MDA5 dermatomyositis (anti-MDA5-DM), but the presence of anti-IFN antibodies remains unclear. This study aims to assess serum levels of anti-IFN-α antibodies in anti-MDA5-DM patients and explore their clinical associati...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Arthritis Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13075-025-03600-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849768899960111104 |
|---|---|
| author | Chao Sun Hongxia Yang Yingfang Zhang Shiyu Wu Xinxin Zhang Wei Jiang Qinglin Peng Guochun Wang Xin Lu |
| author_facet | Chao Sun Hongxia Yang Yingfang Zhang Shiyu Wu Xinxin Zhang Wei Jiang Qinglin Peng Guochun Wang Xin Lu |
| author_sort | Chao Sun |
| collection | DOAJ |
| description | Abstract Background Interferons (IFN) are implicated in the pathogenesis of anti-MDA5 dermatomyositis (anti-MDA5-DM), but the presence of anti-IFN antibodies remains unclear. This study aims to assess serum levels of anti-IFN-α antibodies in anti-MDA5-DM patients and explore their clinical associations. Methods Serum samples from 176 anti-MDA5-DM patients and 55 healthy controls were analyzed for anti-IFN-α antibody levels using an in-house ELISA assay, with immunoblot validation in a subset. Associations between anti-IFN-α antibodies and disease activity or prognosis were assessed. Results The prevalence of anti-IFN-α antibodies in anti-MDA5-DM patients was 17.6% (31/176), with higher rates in those aged over 60 years. Anti-IFN-α antibody-positive patients exhibited significantly higher incidences of RP-ILD (67.7% vs. 41.4%, p = 0.008) and pulmonary infections (74.2% vs. 46.2%, p = 0.005), with fungi, particularly Aspergillus, being the predominant pathogens. Serum anti-IFN-α antibody levels positively correlated with IgG (r = 0.48, p < 0.0001), ESR (r = 0.28, p = 0.003), ferritin (r = 0.16, p = 0.03), lung VAS (r = 0.24, p = 0.01), and PhGA VAS (r = 0.28, p = 0.002). Longitudinal analysis showed that changes in anti-IFN-α antibody levels paralleled changes in skin VAS, lung VAS, and PhGA VAS (p = 0.015, 0.005, and 0.004, respectively). Notably, treatment-aggravated cases had increased anti-IFN-α antibody levels from baseline (p = 0.017), while remission cases showed decreased levels (p = 0.004). Mortality was significantly higher in anti-IFN-α positive patients (Log-rank p = 0.006). Conclusion A subset of anti-MDA5-DM patients demonstrated positive serum anti-IFN-α antibodies. The significant association of these antibodies with disease activity and prognosis suggests their potential as a clinical biomarker. Monitoring anti-IFN-α antibody levels may provide an effective means to assess treatment response and predict outcomes in anti-MDA5-DM. |
| format | Article |
| id | doaj-art-69d6fc2c7508416c99ec2d7a7e5f725d |
| institution | DOAJ |
| issn | 1478-6362 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Arthritis Research & Therapy |
| spelling | doaj-art-69d6fc2c7508416c99ec2d7a7e5f725d2025-08-20T03:03:38ZengBMCArthritis Research & Therapy1478-63622025-07-0127111010.1186/s13075-025-03600-0Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositisChao Sun0Hongxia Yang1Yingfang Zhang2Shiyu Wu3Xinxin Zhang4Wei Jiang5Qinglin Peng6Guochun Wang7Xin Lu8Peking University China-Japan Friendship School of Clinical MedicinePeking University China-Japan Friendship School of Clinical MedicinePeking University China-Japan Friendship School of Clinical MedicinePeking University China-Japan Friendship School of Clinical MedicinePeking University China-Japan Friendship School of Clinical MedicineDepartment of Rheumatology, China-Japan Friendship HospitalDepartment of Rheumatology, China-Japan Friendship HospitalPeking University China-Japan Friendship School of Clinical MedicinePeking University China-Japan Friendship School of Clinical MedicineAbstract Background Interferons (IFN) are implicated in the pathogenesis of anti-MDA5 dermatomyositis (anti-MDA5-DM), but the presence of anti-IFN antibodies remains unclear. This study aims to assess serum levels of anti-IFN-α antibodies in anti-MDA5-DM patients and explore their clinical associations. Methods Serum samples from 176 anti-MDA5-DM patients and 55 healthy controls were analyzed for anti-IFN-α antibody levels using an in-house ELISA assay, with immunoblot validation in a subset. Associations between anti-IFN-α antibodies and disease activity or prognosis were assessed. Results The prevalence of anti-IFN-α antibodies in anti-MDA5-DM patients was 17.6% (31/176), with higher rates in those aged over 60 years. Anti-IFN-α antibody-positive patients exhibited significantly higher incidences of RP-ILD (67.7% vs. 41.4%, p = 0.008) and pulmonary infections (74.2% vs. 46.2%, p = 0.005), with fungi, particularly Aspergillus, being the predominant pathogens. Serum anti-IFN-α antibody levels positively correlated with IgG (r = 0.48, p < 0.0001), ESR (r = 0.28, p = 0.003), ferritin (r = 0.16, p = 0.03), lung VAS (r = 0.24, p = 0.01), and PhGA VAS (r = 0.28, p = 0.002). Longitudinal analysis showed that changes in anti-IFN-α antibody levels paralleled changes in skin VAS, lung VAS, and PhGA VAS (p = 0.015, 0.005, and 0.004, respectively). Notably, treatment-aggravated cases had increased anti-IFN-α antibody levels from baseline (p = 0.017), while remission cases showed decreased levels (p = 0.004). Mortality was significantly higher in anti-IFN-α positive patients (Log-rank p = 0.006). Conclusion A subset of anti-MDA5-DM patients demonstrated positive serum anti-IFN-α antibodies. The significant association of these antibodies with disease activity and prognosis suggests their potential as a clinical biomarker. Monitoring anti-IFN-α antibody levels may provide an effective means to assess treatment response and predict outcomes in anti-MDA5-DM.https://doi.org/10.1186/s13075-025-03600-0Anti-interferon-α antibodyMDA5DermatomyositisDisease activityPrognosis |
| spellingShingle | Chao Sun Hongxia Yang Yingfang Zhang Shiyu Wu Xinxin Zhang Wei Jiang Qinglin Peng Guochun Wang Xin Lu Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis Arthritis Research & Therapy Anti-interferon-α antibody MDA5 Dermatomyositis Disease activity Prognosis |
| title | Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis |
| title_full | Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis |
| title_fullStr | Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis |
| title_full_unstemmed | Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis |
| title_short | Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis |
| title_sort | anti interferon α antibodies associate with disease activity and prognosis in anti mda5 positive dermatomyositis |
| topic | Anti-interferon-α antibody MDA5 Dermatomyositis Disease activity Prognosis |
| url | https://doi.org/10.1186/s13075-025-03600-0 |
| work_keys_str_mv | AT chaosun antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT hongxiayang antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT yingfangzhang antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT shiyuwu antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT xinxinzhang antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT weijiang antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT qinglinpeng antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT guochunwang antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis AT xinlu antiinterferonaantibodiesassociatewithdiseaseactivityandprognosisinantimda5positivedermatomyositis |